Active monitoring improves radiopharmaceutical administration quality

Introduction In 2016, our center adopted technology to routinely monitor 18 F-FDG radiopharmaceutical administrations. Within six months of following basic quality improvement methodology, technologists reduced extravasation rates from 13.3% 2.9% ( p < 0.0001). These same administer other radiopharmaceuticals (without monitoring technology) for general nuclear medicine procedures in a separate facility at the clinic. Our hypothesis was that they would apply lessons-learned 99m Tc-MDP administrations and manual injection rate be consistent with ongoing (3.4%). We tested by methodology added equipment measure Results 816 were monitored during 16-month period (four 4-month periods: A, B, C, D). Period A (first four active monitoring) not statistically different Measure Phase previously completed PET/CT QI Project: 12.75% compared -0.7925). C (months 9–12) D 13–16) rate: 2.94% 3.43% During achieved comparable longstanding Conclusion initial hypothesis, awareness problem steps need correct it result process improvement, accurate. While those factors are important, sufficient. findings suggest associated display results critical efforts reduce sustain rates.